A ngiotensin II (Ang II), a key effector peptide of the renin-angiotensin system (RAS), plays an important role in the control of blood pressure and blood volume. 1 High Ang II concentrations, associated with upregulation of the RAS after ischemia/reperfusion (IR), myocardial infarction (MI), or heart failure, 2 appear to be cardiotoxic and promote injury. Although most cardiovascular effects of Ang II are normally considered to be mediated via Ang II type 1 receptors (AT 1 Rs), recent evidence suggests that in the long term, Ang II type 2 receptors (AT 2 Rs) inhibit growth, promote apoptosis, decrease cellular matrix, decrease blood pressure, dilate glomerular afferent arterioles, increase renal and vascular NO production, and decrease heart rate. 3 Upregulation of AT 2 Rs after chronic MI or in heart failure 4 -6 is thought to mediate ventricular remodeling. Chronic antagonistic interaction between AT 1 R and AT 2 R is thought to be important in vascular remodeling. 3 During chronic AT 1 R blockade, effects of increased Ang II (due to loss of negative feedback on the RAS 7 ) may be mediated by AT 2 R activation, thereby contributing to the cardioprotective effects. 8, 9 The postulated mechanism involves kinin, NO, and cGMP signaling. 10 In the isolated Langendorff (nonworking) rat heart, AT 1 R blockade (produced either acutely or by prior shortterm pretreatment) was reported to improve recovery of left ventricular (LV) function after IR. 11 In the isolated working rat heart, acute AT 2 R blockade with PD 123,319 (PD) produced dramatic improvement of LV function after IR 12 ; however, AT 1 R/AT 2 R status was not determined.
Recently, the inositol 1,4,5-trisphosphate (IP 3 ) type 2 receptor (IP 3 R) was implicated in calcium regulation in myocytes, 13, 14 protein kinase C (PKC) was associated with AT 2 R-mediated effects, 15 and PKC⑀ was associated with cardioprotection involving NO. 16 Thus, we hypothesized that the cardioprotective effect of the AT 2 R blockade during IR in the isolated working rat heart is associated with an increase in AT 2 R mRNA and protein expression as well as with an increase in IP 3 R 13,14 and PKC⑀ 15, 16 proteins but with no change in AT 1 R expression.
The aim of the present study was to determine whether the PD-induced cardioprotective effect during IR is associated with the upregulation of AT 2 R protein and mRNA as well as IP 3 R and PKC⑀ proteins.
Methods

Isolated Working Rat Heart Preparation
As described previously, 12, 17 male Sprague-Dawley rats (250 to 300 g) were anesthetized (sodium pentobarbital, 50 mg/kg IP), and their hearts were rapidly excised and placed in ice-cold Krebs-Henseleit solution. The aorta was cannulated, and initial Langendorff perfusion (10 minutes) was performed. The pulmonary artery and left atrium were cannulated, and the hearts were switched to the working mode by clamping the aortic outflow line and opening the left atrial inflow line. The working hearts were perfused in a closed recirculating system at 37°C in contact with 95% O 2 /5%CO 2 . Atrial pacing (300 bpm) was applied during aerobic perfusion. The perfusate (100 mL) was a modified Krebs-Henseleit solution containing 2.5 mmol/L CaCl 2 , 11 mmol/L glucose, 1.2 mmol/L palmitate prebound to 3% BSA (fraction V), 0.5 mmol/L lactate, and 100 mU/L insulin. Perfusions were made at constant hydrostatic left atrial preload (11.5 mm Hg) and afterload (80 mm Hg). Heart rate, aortic systolic and diastolic pressures, cardiac output, and aortic flow were measured. Coronary flow, LV minute work (in joules), and coronary vascular conductance (expressed as mL ⅐ min Ϫ1 ⅐ mm Hg
Ϫ1
) were calculated.
Experimental Protocol
Hearts were randomly assigned to 4 groups of 6 each: control 1 (no IRϩno PD), control 2 (no IRϩPD), IR (no PD), and IRϩPD (0.3 mol/L). Control hearts were perfused aerobically for 80 minutes in the absence or presence of PD (added after 30-minute aerobic baseline perfusion). Hearts in the IR groups were perfused aerobically in the working mode for 50 minutes and then subjected to 30 minutes of global no-flow ischemia (in the presence or absence of PD). Hearts were not paced during ischemia. After ischemia, the left atrial inflow was reestablished, and pacing was recommenced after 3 minutes of reperfusion. PD was added to the perfusate 5 minutes before the onset of ischemia and remained throughout the reperfusion period. At the end of the experiments, myocardial tissue samples were stored at Ϫ70°C and powdered in liquid nitrogen for analysis of the expression of AT 1 R and AT 2 R protein and mRNA 18, 19 as well as IP 3 R and PKC⑀ proteins.
Western Blot Analysis
Aliquots of powdered tissue (10 mg) were sonicated in homogenization solution (2% SDS, 100 mmol/L dithiothreitol, and 60 mmol/L Tris, pH 6.8) at 4°C and boiled at 100°C. The boiled homogenate was subjected to electrophoresis on a 9% polyacrylamide gel in SDS followed by electrotransfer to nitrocellulose by use of the mini-cell blot electrophoretic transfer system (Bio-Rad) at 4°C. The nitrocellulose membranes were then blocked with PBS supplemented with 5% (wt/vol) skimmed milk powder and 0.05% (vol/vol) Tween 20 at room temperature. For AT 1 R protein, the nitrocellulose membranes were incubated with affinity-purified rabbit anti-human AT 1 R antibody (Santa Cruz Biotechnology Inc) at a dilution of 1:2000 for 2 hours at room temperature. The membranes were washed with PBS-Tween 20 (0.05%) 3 times, then incubated with goat anti-rabbit IgG antibody conjugated to peroxidase, and visualized by use of chemiluminescence detection (ECL Western blot kit, Amersham). The intensity of bands was quantified by scanning densitometry with the use of image analysis software (Sigma Chemical Co). The same procedure used for AT 1 R was used for AT 2 R proteins, except that incubation with goat anti-human AT 2 R antibody (Santa Cruz Biotechnology Inc) at a dilution of 1:500 was followed by incubation with donkey anti-goat IgG (BioCan Scientific). The same procedure used for AT 1 R was used for the detection of IP 3 R and PKC⑀ proteins, except for an incubation with goat anti-human nPKC⑀ and IP 3 type 2 antibodies (Santa Cruz) at a dilution of 1:100, followed by incubation with donkey anti-goat IgG. Gel transfer efficiency and retention were confirmed with reversible ponceau staining and Coomassie blue staining, respectively. Immunoblots were performed in triplicate, and the results were averaged.
cDNA Probe Preparation
cDNA for AT 1a R and AT 2 R were used to prepare probes for analysis of rat AT 1 R and AT 2 R mRNA. Human AT 2 R and mouse AT 1a R cDNA were subcloned 20 into plasmid pcDNA3. The plasmid DNA was then digested with the use of 2 restriction enzymes that flanked the cDNA for the receptors. A 1.1-kb fragment corresponding to the coding region of the human AT 2 R cDNA was isolated from the plasmid via a restriction enzyme digest with EcoRI (BoehringerMannheim). The plasmid containing mouse AT 1a R cDNA was restriction enzyme-digested with HindIII and BamHI (BoehringerMannheim), removing a 1.1-kb fragment corresponding to the coding region of the mouse AT 1a R cDNA. In both cases, the cDNA was gel-purified, and 25 ng of each was labeled with [ 
Northern Blot Analysis
Total RNA was extracted from rat myocardium by use of the acid guanidinium-thiocyanate-phenol-chloroform extraction method with TRIzol reagent (GIBCO-BRL). Aliquots (20 g) of total RNA were size-fractionated by electrophoresis on a 1.0% agarose/3% formaldehyde gel. These RNA samples were then transferred to Nytran membranes (Schleicher and Schuell Co). Probes were labeled with [␣-32 P]dCTP by using a random primer method. The labeled probes were separated from unincorporated nucleotides by using Sephadex G-50 spin columns. After ultraviolet cross-linking for 30 seconds, the membranes were prehybridized in the solution mixture containing 50% formamide, 5ϫ SSC, 5ϫ Denhardt's solution, 0.1% SDS, 0.05 mol/L sodium phosphate buffer (pH 6.8), 0.1% sodium pyrophosphate, and 50 g/mL sheared herring sperm DNA at 42°C for 3 hours. The membranes were then hybridized with a 32 P-labeled probe specific for AT 1a R and AT 2 R in the same buffer for 18 to 24 hours at 42°C. Membranes were washed successively at room temperature in 2ϫ SSC containing 0.1% SDS for 30 minutes twice and 1ϫ SSC containing 0.1% SDS for 30 minutes and then at 55°C in 0.2ϫ SSC containing 0.1% SDS for 45 minutes. Membranes were exposed at Ϫ80°C for 1 to 2 weeks on Kodak X-OMAT film (Eastman Kodak). Autoradiograms were quantified by scanning densitometry with the use of image analysis software (Sigma). GAPDH was used to normalize differences in loaded and transferred mRNA.
Statistics
Values shown are meanϮSEM. Data were analyzed by ANOVA (with repeated measures followed by a Student t test with the Bonferroni correction for repeated comparisons) and linear regression analysis. Statistical significance was set at PϽ0.05.
Results
Effect of PD on Recovery of Function
In agreement with previous findings, 12 PD improved recovery of postischemic LV work compared with IR alone (Figure 1) . Baseline values of LV work for IRϩno PD, IRϩPD, no IRϩno PD, and no IRϩPD groups were similar (1.04Ϯ0.02, 1.09Ϯ0.03, 1.02Ϯ0.01, and 1.01Ϯ0.01 J, respectively). In the no IRϩno PD group, there was no change in LV work during continued aerobic perfusion to 80 minutes, and the addition of PD had no effect. In the IR group, recovery of LV work during reperfusion was significantly depressed to 51Ϯ9% of the baseline value (PϽ0.001), and PD significantly improved recovery to 85Ϯ4% (PϽ0.05 versus IR). With PD, LV work during reperfusion did not differ from baseline (PϭNS).
Coronary flow and cardiac output were similar in the 4 groups during baseline perfusion, were unchanged with no IRϩPD, became depressed after IR, and improved during IRϩPD.
However, coronary vascular conductance did not change with no IRϩPD or IRϩPD. 
Effect of PD on AT 2 R Protein and mRNA
Effect of PD on IP 3 R and PKC⑀ Proteins
Discussion
Although the cardioprotective effect of acute AT 2 R blockade with PD on recovery of LV mechanical function after IR in the isolated working rat heart has been previously reported, 12 the status of AT 2 Rs/AT 1 Rs associated with this response remains unclear. The major new finding in the present study is that the cardioprotective effect is specifically due to AT 2 R blockade. Thus, PD increased AT 2 R protein and mRNA expression but did not change AT 1 R protein or mRNA. A second new finding is that this upregulation of AT 2 Rs was associated with marked increase in IP 3 R and PKC⑀ proteins, suggesting that the cardioprotection associated with AT 2 R upregulation might involve downstream IP 3 R and PKC⑀ signaling.
In the present study, the downregulation of both AT 1 R and AT 2 R with acute IR is consistent with receptor activation in response to the release of Ang II, whereas the upregulation of AT 2 R alone after PDϩIR is consistent with the effect of a selective antagonist. The lack of changes in AT 1 R mRNA and protein in control groups (no IRϮPD) indicates that the effect on AT 2 R mRNA and protein with IRϩPD was not a nonspecific effect but was specifically due to PD-induced AT 2 R blockade. The rapid increase in AT 2 R mRNA followed by protein with IRϩPD and the rapid downregulation of AT 2 R mRNA and protein with IR is consistent with the pattern seen with other signal transduction pathways during ischemia, such as for ␤-adrenoceptors 21 and ␤-adrenoceptor kinase. 22 Importantly, IR decreased IP 3 R and PKC⑀ proteins.
The signaling mechanisms for acute or chronic stimulation of AT 2 R are not as well defined as for AT 1 R. 2, 3 Useful insights into chronic signaling mechanisms were gained from studies using chronic pretreatment with AT 1 R blockers before IR; chronic treatment in MI, hypertrophy, or heart failure; gene deletion in AT 2 R knockout mice; and chronic AT 2 R overexpression. 2, 3 However, such chronic manipulations may alter populations and the expression and interactions of receptors and cause adaptive alterations in several unrelated proteins. In the present study, we determined the acute effects of AT 2 R blockade in isolated working adult rat hearts. Although we did not directly measure Ang II release after IR, corroborative evidence 23, 24 suggests that the receptors might be exposed to a local increase in Ang II during IR. Acting via AT 1 R, Ang II increases IP 3 and calcium and induces coronary vasoconstriction and a positive inotropic effect. 25 AT 1 R signaling involves tyrosine kinase-mediated phosphorylation of downstream kinases and substrates, calciumdependent events mediated by phospholipase C, and inhibition of adenyl cyclase. 21, 26 Stimulation of phospholipase C leads to the generation of IP 3 and diacylglycerol as second messengers. Some steps in AT 2 R signaling include activation of protein tyrosine phosphatase, inhibition of extracellular signal-regulated kinase, dephosphorylation of Bcl-2 protein, stimulation of ceramide production, and activation of the kinin/NO/cGMP system. 3 The latter mechanism was proposed to contribute to benefits of high Ang II levels during AT 1 R blockade, 8, 9 but whether high Ang II levels can induce cardioprotection via AT 2 R activation in the absence of AT 1 R blockade has not been established.
In the present study, the coincident increase in AT 2 R, IP 3 R, and PKC⑀ proteins during PD-induced cardioprotection suggests that enhanced expression of these proteins by PDϩIR is functionally important. PKC signaling has been characterized during ischemic preconditioning 27 and ischemia, 28 and PKC activation mediates inotropic responses. 28 Ping et al 16 established that cardioprotection induced by late preconditioning involves NO-induced activation of PKC⑀ and that the increase in PKC⑀ is not an epiphenomenon. PKC⑀ activation has also been implicated in cardioprotection induced by ethanol in guinea pig hearts 29 and hypoxia-induced early preconditioning in neonatal rat myocytes. 30 Our finding of increased PKC⑀ protein in association with PD-induced cardioprotection during IR, but not in association with the control groups or IR alone, supports the idea that PKC⑀ might be a commonly shared critical downstream effector of the cardioprotective response. We are unaware of other reports of IP 3 R upregulation in IR or in MI, hypertrophy, and heart failure.
Although these findings suggest that the acute cardioprotective effect of AT 2 R blockade involves IP 3 R and PKC⑀ signaling ( Figure 5 ), the precise mechanisms have not yet been established. This might involve NO-dependent signaling. NO has been implicated in the modulation of cardiac function. 31 A mechanism that might have participated in the cardioprotective effect of AT 2 R blockade involves inhibition of apoptosis. Thus, apoptosis is accelerated by AT 2 R 32 and contributes to LV dysfunction after acute IR, 33 whereas its inhibition limits the dysfunction. 34 Another intriguing mechanism is that during AT 2 R blockade, increased Ang II levels might mediate AT 1 R activation, the converse of the AT 2 R activation paradigm during AT 1 R blockade. This increased AT 1 R activation could elicit positive inotropism 25 via an increase in IP 3 and PKC. 21 With AT 2 R blockade by PD, AT 2 R downstream signaling is impaired, AT 2 R is markedly upregulated, and IP 3 R and PKC⑀ are also modestly upregulated, suggesting that AT 2 R signaling involves IP 3 R and PKC⑀. Endogenous mediators that signal through IP 3 R and PKC⑀ are enhanced, resulting in cardioprotection. Thus, enhanced IP 3 R and PKC⑀ might prime the tissues to the mediators independent of Ang II. Alternatively, Ang II acting via AT 1 R (unchanged [7] with IRϩPD) might have participated in cardioprotection.
The present study has several limitations. First, the isolated heart does not provide insight into chronic effects. Second, it does not allow localization of the changes in proteins to regions or cell types. Third, we did not measure PKC⑀ activity. Nevertheless, the finding that acute AT 2 R blockade can be cardioprotective during IR may have important implications for human cardiovascular diseases, such as hypertension, MI, and congestive heart failure. The main reasons are that (1) AT 2 Rs are more prevalent in human than rat hearts, 35 (2) AT 2 Rs are upregulated in those disease states, 6 (3) most Ang II in human hearts comes from non-angiotensin-converting enzyme pathways, such as chymase, 36 so that AT 1 R blockade with or without angiotensinconverting enzyme inhibition is being proposed for therapy, and (4) patients with the above conditions are prone to acute coronary syndromes and are likely to undergo reperfusion. Whether acute AT 2 R blockade might be beneficial (or harmful) in vivo in the absence of AT 1 R blockade requires detailed investigation.
In conclusion, the cardioprotective effect of acute AT 2 R blockade in isolated adult rat hearts is associated with the upregulation of AT 2 R mRNA and protein as well as with increased IP 3 R and PKC⑀ proteins. The findings suggest that the cardioprotective effect is associated with IP 3 R and PKC⑀ signaling.
